PHAR - CEO of Pharming to present at H.C. Wainwright 24th Annual Global Investment Conference

PR Newswire

LEIDEN, The Netherlands , Sept. 7, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that its Chief Executive Officer, Sijmen de Vries, will present at the H.C. Wainwright 24 ^th Annual Global Investment Conference, a hybrid meeting based in New York , at the Lotte Palace Hotel, September 12-14 , 2022.

Pharming Group N.V.'s CEO will present on Tuesday, September 13 at 09:30 ET / 15:30 CET .

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your H.C. Wainwright representative, or send an email to Pharming's Investor Relations team to investor@pharming.com

About Pharming Group N.V.

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands , and has employees around the globe who serve patients in over 30 markets in North America , Europe , the Middle East , Africa , and Asia-Pacific .

For more information, visit www.pharming.com or follow us on LinkedIn .

For further public information, contact:

Pharming Group, Leiden, The Netherlands
Heather Robertson, Investor Relations & Corporate Communications Manager
T: +31 71 5247 400
E: investor@pharming.com

FTI Consulting, London, UK
Victoria Foster Mitchell / Alex Shaw
T: +44 203 727 1000

FTI Consulting, USA
Jim Polson
T: +1 (312) 553-6730

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Logo - https://mma.prnewswire.com/media/1454235/Pharming_Group_NV_Logo.jpg

SOURCE Pharming Group N.V.